Recombinant CD79B (Iladatuzumab Biosimilar) antibody
The Humanized Chimeric anti-CD79B (Iladatuzumab Biosimilar) antibody is suitable to detect CD79B (Iladatuzumab Biosimilar) in samples from Human.
Catalog No. ABIN7597741
$401.14
Plus shipping costs $50.00, if applicable $20.00 dry ice
Shipping to:
United States
Delivery in 12 to 15 Business Days
Quick Overview for Recombinant CD79B (Iladatuzumab Biosimilar) antibody (ABIN7597741)
Target
CD79B (Iladatuzumab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Humanized
Clonality
Chimeric
Conjugate
This CD79B (Iladatuzumab Biosimilar) antibody is un-conjugated
Grade
Research Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Research Grade Iladatuzumab Biosimilar Antibody
-
Specificity
- B-cell-specific glycoprotein B29, CD79B, B-cell antigen receptor complex-associated protein beta chain, Ig-beta, B29, Immunoglobulin-associated B29 protein, IGB, CD79b
-
Purification
- Protein A or G purified from cell culture supernatant.
-
Purity
- >95 % by SDS-PAGE.
-
Isotype
- IgG1 kappa
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 3.42 mg/mL
-
Buffer
- 0.01M PBS, pH 7.4.
-
Storage
- 4 °C,-20 °C,-80 °C
-
Storage Comment
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
-
Expiry Date
- 12 months
-
-
- CD79B (Iladatuzumab Biosimilar)
-
Alternative Name
- Iladatuzumab Biosimilar
-
Target Type
- Biosimilar
-
Background
- B-cell-specific glycoprotein B29, CD79B, B-cell antigen receptor complex-associated protein beta chain, Ig-beta, B29, Immunoglobulin-associated B29 protein, IGB, CD79b
-
UniProt
- P40259
-
CAS-No
- 1906205-76-2
Target
-
You are here:
